Metropolis Healthcare Limited
Metropolis Healthcare Ltd. reported strong Q4 FY26 and full-year FY26 performance, with group revenue up 23% and 23.6% respectively. The company targets 14-15% CAGR revenue growth and 27-28% group EBITDA margin over the next three years, driven by organic growth and strategic initiatives.
May 19 2026 19:05:00
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Metropolis Healthcare has made the audio recording of its Q4 FY26 earnings conference call available on its official website. This recording, from the call held on May 14, 2026, provides detailed discussions on the company's financial results for the quarter.
May 14 2026 16:05:00
Metropolis Healthcare sees strong Q4 performance driven by specialty and preventive testing push
Metropolis Healthcare reported a strong performance for Q4 FY26, with consolidated net profit increasing by 75% year-on-year to ₹51 crore and revenue from operations growing 23% to ₹425 crore. This robust growth was driven by higher patient volumes, increased test volumes, significant B2C and B2B revenue growth, and an expanded focus on specialty and preventive testing, leading to improved EBITDA margins.
May 14 2026 14:05:00
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Metropolis Healthcare reported strong Q4 FY26 unaudited consolidated financial results with revenue increasing 23% YoY to Rs.425 crore, and net profit soaring 75% YoY to Rs.51 crore, driven by robust demand and operational efficiencies.
May 13 2026 20:05:00
Metropolis Healthcare Limited
Metropolis Healthcare declared an interim dividend of Re. 1 per equity share for FY 2025-26. The record date for this dividend has been fixed as May 19, 2026, indicating shareholder eligibility.
May 13 2026 19:05:00
Metropolis Healthcare Ltd - 542650 - Corporate Action-Board approves Dividend
Metropolis Healthcare announced a 2nd interim dividend of ₹1 per equity share for FY26. The record date for this dividend is May 19, 2026, with payments expected within 30 days of the declaration.
May 13 2026 18:05:00
Metropolis Healthcare Ltd - 542650 - Board Meeting Outcome for The Meeting Held Today (May 13, 2026)
Metropolis Healthcare reported strong Q4 FY26 cons. results: revenue climbed 23% YoY to ₹424.68 Cr, and net profit increased 74% to ₹50.96 Cr. The board also declared a ₹1 interim dividend for FY26, with May 19, 2026, as the record date.
May 13 2026 18:05:00
Metropolis Healthcare Limited
Metropolis Healthcare's Board is scheduled to meet on May 13, 2026. The agenda includes considering and approving the audited annual financial results for the financial year ended March 2026 and declaring an interim dividend.
May 07 2026 18:05:00
Metropolis Healthcare Limited
Metropolis Healthcare's Board is scheduled to meet on May 13, 2026. The agenda includes considering the yearly audited standalone and consolidated financial results for FY26 and an interim dividend declaration.
May 07 2026 18:05:00
Metropolis Healthcare Ltd - 542650 - Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31, 2026 And Declaration Of 2Nd Interim Dividend, If Any, For The Financial Year 2025-26
Metropolis Healthcare's board will convene on May 13, 2026, to review and approve the audited financial results for Q4 and the full fiscal year ended March 31, 2026. The board will also consider declaring a 2nd interim dividend for FY26.
May 07 2026 18:05:00
Read More